Temodar, MGMT Methylation, and the Endless Loop of Bad Glioblastoma Treatments

Understanding why half of patients will take a drug offering little to no benefit.

Source: Depth-First - August 6, 2023 Category: Chemistry Authors: Richard L. Apodaca Source Type: blogs